/
GDTC
$0.85+$0.04 (+4.51%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.6M
12M shares
52-week range
$0.68 – $3.68
5% from low
Exchange
NASDAQ
CS
Change$-3.16
CytoMed Therapeutics Limited Ordinary Shares
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
w2.cytomed.sg- Employees
- 42
- IPO / List date
- Apr 14, 2023
Held by traders on TradeandTell
No one on the platform currently holds GDTC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GDTC as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GDTC yet.
